UCB Is RADIANT As Bimekizumab Beats Cosentyx For Psoriasis

IL-17A And IL-17F Inhibitor Just Filed In US And Europe

 
• By Kevin Grogan
  
Caterpillars
Novartis bested by UCB in head-to-head study • Source: Shutterstock

More from Immunological

More from Therapy Areas